{"id":512897,"date":"2021-07-14T08:33:16","date_gmt":"2021-07-14T12:33:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/"},"modified":"2021-07-14T08:33:16","modified_gmt":"2021-07-14T12:33:16","slug":"cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/","title":{"rendered":"Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets"},"content":{"rendered":"

<\/p>\n

Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets<\/b><\/p>\n

The Swiss Red Cross is a global pioneer in the nationwide adoption of Cerus\u2019 pathogen inactivation technology<\/i><\/p>\n

CONCORD, Calif.–(BUSINESS WIRE<\/a>)–
\nCerus Corporation (Nasdaq: CERS), a company solely dedicated to safeguarding the global blood supply, and the Transfusion Service of the Swiss Red Cross (Blutspende SRK Schweiz) announced today the tenth anniversary of the use of the INTERCEPT Blood System for its entire platelet supply in Switzerland.\n<\/p>\n

\n\u201cWe are honored to mark the tenth anniversary of the routine use of INTERCEPT platelets with our long-time partners at the Swiss Red Cross,\u201d stated William \u2018Obi\u2019 Greenman, president and chief executive officer of Cerus Corporation. \u201cThe transfusion medicine community in Switzerland has long been vigilant with regard to blood safety and was among the earliest adopters of our technology at scale. The Swiss Red Cross recognized early on the value in implementing a proactive, \u2018always on\u2019 approach to increasing the safety of the country\u2019s platelet supply. In this era of pandemic preparedness, we look forward to supporting their pioneering vision around blood safety and availability.\u201d\n<\/p>\n

\nSince the Swiss Red Cross implemented the INTERCEPT Blood System for platelets, Cerus has provided INTERCEPT platelet kits for approximately 400,000 transfusable platelet units in Switzerland with no reports of transfusion-transmitted infections, transfusion-associated sepsis cases, fatalities or other long-term adverse side effects observed. Additionally, hemovigilance data for Switzerland\u2019s routine use of INTERCEPT platelets have shown no increase in the use of platelets to treat patients.\n<\/p>\n

\n\u201cCerus and the INTERCEPT platform have been essential contributors to our success in providing for the safety and availability of the platelet supply in Switzerland over the last decade. The INTERCEPT System\u2019s ability to inactivate bacteria has given us peace of mind in the ability to transfuse patients without the threat of contamination,\u201d stated Bernhard Wegm\u00fcller, chairman and chief executive officer of the Swiss Red Cross Transfusion Service. \u201cWith emerging pathogens now fully recognized as a continued reality in medicine, we are further assured by the additional layer of safety that this technology provides for our patients receiving platelet transfusions,\u201d Mr. Wegm\u00fcller continued.\n<\/p>\n

\n\u201cAs the FDA compliance deadline for bacterial contamination of platelets comes upon us in the U.S., the experiences of blood centers that pioneered the use of our pathogen inactivation technology, like the Swiss Red Cross, have amassed a significant amount of experience with the INTERCEPT Blood System that supports its continued adoption globally. Active hemovigilance data encompassing many years of routine use by the SRK and others underscore the utility and reliability of the INTERCEPT Blood System in safeguarding the global blood supply,\u201d added Mr. Greenman.\n<\/p>\n

ABOUT CERUS<\/b><\/p>\n

\nCerus Corporation is dedicated solely to safeguarding the world\u2019s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for the production of INTERCEPT Fibrinogen Complex, a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. For more information about Cerus, visit www.cerus.com<\/a> and follow us on LinkedIn.\n<\/p>\n

\nINTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210714005301\/en\/<\/a><\/span><\/p>\n

\nMatt Notarianni \u2013 Senior Director, Investor Relations
\n
Cerus Corporation
\n
925-288-6137\n<\/p>\n

KEYWORDS:<\/b> Europe Switzerland United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> FDA Medical Devices Infectious Diseases Health Medical Supplies<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets The Swiss Red Cross is a global pioneer in the nationwide adoption of Cerus\u2019 pathogen inactivation technology CONCORD, Calif.–(BUSINESS WIRE)– Cerus Corporation (Nasdaq: CERS), a company solely dedicated to safeguarding the global blood supply, and the Transfusion Service of the Swiss Red Cross (Blutspende SRK Schweiz) announced today the tenth anniversary of the use of the INTERCEPT Blood System for its entire platelet supply in Switzerland. \u201cWe are honored to mark the tenth anniversary of the routine use of INTERCEPT platelets with our long-time partners at the Swiss Red Cross,\u201d stated William \u2018Obi\u2019 Greenman, president and chief executive officer of Cerus … <\/p>\n

Continue reading “Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-512897","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets The Swiss Red Cross is a global pioneer in the nationwide adoption of Cerus\u2019 pathogen inactivation technology CONCORD, Calif.–(BUSINESS WIRE)– Cerus Corporation (Nasdaq: CERS), a company solely dedicated to safeguarding the global blood supply, and the Transfusion Service of the Swiss Red Cross (Blutspende SRK Schweiz) announced today the tenth anniversary of the use of the INTERCEPT Blood System for its entire platelet supply in Switzerland. \u201cWe are honored to mark the tenth anniversary of the routine use of INTERCEPT platelets with our long-time partners at the Swiss Red Cross,\u201d stated William \u2018Obi\u2019 Greenman, president and chief executive officer of Cerus … Continue reading "Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-14T12:33:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210714005301r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets\",\"datePublished\":\"2021-07-14T12:33:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\\\/\"},\"wordCount\":675,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210714005301r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\\\/\",\"name\":\"Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210714005301r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-07-14T12:33:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210714005301r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210714005301r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/","og_locale":"en_US","og_type":"article","og_title":"Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets - Market Newsdesk","og_description":"Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets The Swiss Red Cross is a global pioneer in the nationwide adoption of Cerus\u2019 pathogen inactivation technology CONCORD, Calif.–(BUSINESS WIRE)– Cerus Corporation (Nasdaq: CERS), a company solely dedicated to safeguarding the global blood supply, and the Transfusion Service of the Swiss Red Cross (Blutspende SRK Schweiz) announced today the tenth anniversary of the use of the INTERCEPT Blood System for its entire platelet supply in Switzerland. \u201cWe are honored to mark the tenth anniversary of the routine use of INTERCEPT platelets with our long-time partners at the Swiss Red Cross,\u201d stated William \u2018Obi\u2019 Greenman, president and chief executive officer of Cerus … Continue reading \"Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-14T12:33:16+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210714005301r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets","datePublished":"2021-07-14T12:33:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/"},"wordCount":675,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210714005301r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/","name":"Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210714005301r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-07-14T12:33:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210714005301r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210714005301r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of-intercept-blood-system-for-platelets\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/512897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=512897"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/512897\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=512897"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=512897"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=512897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}